Fraxa Research Foundation

Unspecified (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£347,248

May 13 - Oct 14

Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug

MRC award to University College London

£1,980,780

May 19 - Dec 21

LIMK1 inhibitors - A novel, disease-modifying approach for the treatment of fragile X syndrome

MRC award to Cardiff University and Simon Ward

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}